Cargando…
A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493136/ https://www.ncbi.nlm.nih.gov/pubmed/37700811 http://dx.doi.org/10.2147/CMAR.S438711 |
Ejemplares similares
-
A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
por: Liu, Yajiao, et al.
Publicado: (2023) -
Germline mutations predisposing to diffuse large B-cell lymphoma
por: Leeksma, O C, et al.
Publicado: (2017) -
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma
por: Kusano, Y, et al.
Publicado: (2017) -
Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Zhang, Tingting, et al.
Publicado: (2021) -
The evolution of IBP
Publicado: (1977)